Vaccines, blood, antisera, toxins and cultures in   Thailand

Exports In 2022, Thailand exported $70.8M in Vaccines, blood, antisera, toxins and cultures, making it the 43rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 383rd most exported product in Thailand. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Thailand are: Vietnam ($16.2M), Malaysia ($8.9M), Burma ($8.76M), Chinese Taipei ($6.99M), and Australia ($6.98M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Thailand between 2021 and 2022 were Burma ($7.19M), Australia ($6.58M), and Cambodia ($5.66M).

Imports In 2022, Thailand imported $1.34B in Vaccines, blood, antisera, toxins and cultures, becoming the 31st largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 39th most imported product in Thailand. Thailand imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($357M), Belgium ($244M), United States ($230M), Sweden ($92M), and Switzerland ($77.3M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Thailand between 2021 and 2022 were Germany ($101M), Sweden ($91.8M), and United States ($65.7M).